Position in CABA
as of Jun 30, 2026
· filed Aug 3, 2026
Position Value
$572,960
+$499,058 QoQ
Shares Held
184,232
+570.6% QoQ
Ownership
0.109%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#52
of 139 holders
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in CABA Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026CITIGROUP INC holds $2,077,377,990 across 384 Biotechnology names. CABA ranks #172 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
706,968 | $351,172,214 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
346,637 | $216,142,034 | |
| 3 | MRNA |
Moderna, Inc.
|
2,165,414 | $151,643,941 | |
| 4 | ROIV |
Roivant Sciences Ltd.
|
2,225,190 | $78,749,472 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
227,786 | $68,570,419 | |
| 6 | INCY |
Incyte Corp
|
586,431 | $66,477,817 | |
| 7 | BBIO |
BridgeBio Pharma, Inc.
|
864,101 | $64,358,241 | |
| 8 | RVMD |
Revolution Medicines, Inc.
|
247,052 | $46,267,897 |
All Filings in CABA
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $572,960 | 184,232 | Shares | Defined | 2026-08-03 | |
| 2026-03-31 | $73,902 | 27,473 | Shares | Defined | 2026-05-11 | |
| 2025-12-31 | $161,565 | 73,774 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $823 | 352 | Shares | Defined | 2025-11-10 | |
| 2025-06-30 | $94,998 | 62,499 | Shares | Defined | 2025-08-11 | |
| 2025-03-31 | $43,574 | 31,462 | Shares | Defined | 2025-05-12 | |
| 2024-12-31 | $81,161 | 35,754 | Shares | Defined | 2025-02-12 | |
| 2024-09-30 | $163,150 | 34,566 | Shares | Defined | 2024-11-12 | |
| 2024-06-30 | $171,245 | 22,894 | Shares | Defined | 2024-08-12 | |
| 2024-03-31 | $5,150,174 | 301,886 | Shares | Defined | 2024-05-10 | |
| 2023-12-31 | $1,964,593 | 86,546 | Shares | Defined | 2024-02-09 | |
| 2023-09-30 | $756,357 | 49,695 | Shares | Defined | 2023-12-06 | |
| 2023-06-30 | $98,335 | 7,617 | Shares | Defined | 2023-08-10 | |
| 2023-03-31 | $378,369 | 45,752 | Shares | Defined | 2023-05-11 | |
| 2022-09-30 | $221 | 340 | Shares | Defined | 2022-11-10 | |
| 2022-06-30 | $463 | 437 | Shares | Defined | 2022-08-10 | |
| 2022-03-31 | $3,645 | 1,796 | Shares | Defined | 2022-05-12 | |
| 2021-12-31 | $9,334 | 2,463 | Shares | Defined | 2022-02-10 | |
| 2021-09-30 | $24,283 | 1,997 | Shares | Defined | 2021-11-10 | |
| 2021-06-30 | $12,994 | 1,511 | Shares | Defined | 2021-08-10 | |
| 2021-03-31 | $14,596 | 1,315 | Shares | Defined | 2021-05-13 | |
| 2020-12-31 | $54,462 | 4,364 | Shares | Defined | 2021-02-11 | |
| 2020-09-30 | $12,151 | 1,121 | Shares | Defined | 2020-11-12 | |
| 2020-06-30 | $24,563 | 2,205 | Shares | Defined | 2020-08-12 | |
| 2020-03-31 | $13,906 | 1,905 | Shares | Defined | 2020-05-12 | |
| No filing history on record for this holder in this stock. | ||||||